Di Salvo et al. [34] found that deprived Italian women with ER+ tumours had a substantially higher five-year risk of recurrence than the least deprived women with ER+ tumours even after adjusting for stage and stratifying for hormone receptor status and age. The gene discussed is NR4A1; the disease is neoplasm.